載入...

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.

BACKGROUND:Dolutegravir (DTG) is a once-daily unboosted second-generation integrase-inhibitor that along with two nucleoside reverse transcriptase inhibitors is one of several regimens recommended by the United States, United Kingdom and European Union for first-line antiretroviral treatment of peop...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: George W Rutherford, Hacsi Horvath
格式: Artigo
語言:Inglês
出版: Public Library of Science (PLoS) 2016-01-01
叢編:PLoS ONE
在線閱讀:http://europepmc.org/articles/PMC5063380?pdf=render
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!